CHMG trades 32.7% above Wall Street's consensus target of $50.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CHMG achieves its forward estimates and maintains a stable P/E multiple of 10.4x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Chemung Financial Corporation (CHMG) has a Wall Street consensus price target of $50.00, based on estimates from 7 covering analysts. With the stock currently trading at $74.33, this represents a potential downside of -32.7%. The company has a market capitalization of $358M.
Analyst price targets range from a low of $50.00 to a high of $50.00, representing a 0% spread in expectations. The median target of $50.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CHMG trades at a trailing P/E of 23.7x and forward P/E of 10.4x. Analysts expect EPS to grow +88.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $63.63, with bear and bull scenarios of $40.09 and $83.84 respectively. Model confidence stands at 46/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CZWICitizens Community Bancorp, Inc. | $225M | $23.29 | — | — | Buy | 12.8x | 2 |
FUNCFirst United Corporation | $283M | $43.96 | $50.00 | +13.7% | Buy | 10.1x | 1 |
PBHCPathfinder Bancorp, Inc. | $99M | $15.95 | — | — | — | — | — |
CFFIC&F Financial Corporation | $260M | $80.00 | — | — | — | 7.8x | — |
AROWArrow Financial Corporation | $675M | $40.82 | $43.00 | +5.3% | Hold | 10.9x | 1 |
NBTBNBT Bancorp Inc. | $2.6B | $49.63 | $56.00 | +12.8% | Hold | 11.9x | 10 |
STBAS&T Bancorp, Inc. | $1.8B | $49.92 | $51.00 | +2.2% | Hold | 13.4x | 12 |
FXNCFirst National Corporation | $265M | $29.30 | $21.00 | -28.3% | Buy | 12.4x | 1 |
TRSTTrustCo Bank Corp NY | $956M | $54.71 | — | — | Hold | 19.1x | 3 |
FISFidelity National Information Services, Inc. | $22.0B | $42.60 | $62.88 | +47.6% | Buy | 6.8x | 37 |
Quick answers to the most common questions about buying CHMG stock.
CHMG's consensus price target is $50, -32.7% below the current price of $74.33. The 7 analysts tracking CHMG see downside risk at present valuations.
CHMG has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $50 implies -32.7% downside from current levels.
With a forward P/E of 10.3958x, CHMG trades at a relatively low valuation. The consensus target of $50 implies -32.7% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $50 for CHMG, while the most conservative target is $50. The consensus of $50 represents the median expectation. Our quantitative valuation model projects a bull case target of $84 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHMG is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHMG stock forecast based on 7 Wall Street analysts shows a consensus price target of $50, with estimates ranging from $50 (bear case) to $50 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $64, with bear/bull scenarios of $40/$84.
Our quantitative valuation model calculates CHMG's fair value at $64 (base case), with a bear case of $40 and bull case of $84. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.
CHMG trades at a forward P/E ratio of 10.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CHMG, with 0 Sell ratings and a price target of $50 (-32.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHMG analyst price targets range from $50 to $50, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $50 consensus represents the middle ground. Our model's $40-$84 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.